France· FR:61858889
PAVBLU 40 mg/mL, solution injectable en seringue préremplie
A medicinal product containing aflibercept, registered in France by AMGEN TECHNOLOGY (IRELAND), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- AFLIBERCEPT
- Manufacturer
- AMGEN TECHNOLOGY (IRELAND)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009303131761 seringue préremplie polyoléfine cyclique (COP) de 0,09 mLEUR 247.76
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aflibercept in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAFIVEGSTADA Arzneimittel AG, Bad Vilbel
- BelgiumAfiveg 40 mg/mlStada Arzneimittel
- SwedenAfiveg 40 mg/ml Injektionsvätska, lösningSTADA Arzneimittel AG
- IcelandAfivegSTADA Arzneimittel AG
- PolandAfivegSTADA Arzneimittel AG
- NetherlandsAfiveg 40 mg/ml oplossing voor injectieStada Arzneimittel AG
- SpainAFQLIR 40 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADASandoz Gmbh
- IrelandAfiveg 40 mg/mL solution for injectionStada Arzneimittel AG
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Vgenfli
- Iceland · Afiveg, Afqlir
- Liechtenstein · Afiveg, Afqlir
- Norway · Afiveg, Afqlir
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b942bad8-bbd0-439c-852e-31bb64ad6230 GET /v1/drugs/b942bad8-bbd0-439c-852e-31bb64ad6230?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61858889",
"date_amm": "2025-04-04",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/25/1909",
"substance": "AFLIBERCEPT",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intravitréenne",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about aflibercept.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.